Author(s): Vikash Gupta, Mohan Lal Kori


DOI: 10.52711/0974-360X.2023.00263   

Address: Vikash Gupta, Mohan Lal Kori*
Vedica College of B. Pharmacy, RKDF University, Airport Bypass Road, Gandhi Nagar, Bhopal (M.P.) India. 462033.
*Corresponding Author

Published In:   Volume - 16,      Issue - 4,     Year - 2023

Diabetes is a chronic and group of metabolic disease which might lead to severe associated complications. Many synthetic anti-diabetic drugs used in first line treatment does not significantly control nor protect other organs from diabetes associated damage, but it increases the risk of developing complications due to their adverse effects. Hence, present research was designed to develop and evaluate polyherbal anti-diabetic formulations for the management of diabetes and its complications associated with liver, kidney and hematological parameters. Ethanolic extracts (50%) of four plants including calyx of Hibiscus sabdariffa (H), leaves of Annona squamosa (A), stem bark of Ficus religiosa (F) and leaves of Aegle marmelos (A), i.e., HAFA, were used for development of formulations by using geometrical dilution methods, which were named HAFA 1 to HAFA 24. To identify the most effective formulations, they were evaluated using oral glucose tolerance test (OGTT) in normal rats. Four most effective HAFA formulations selected were subjected to hypoglycemic study in normal rats, acute and sub-acute anti-hyperglycemic activity in streptozotocin-nicotinamide induced diabetic rats. HAFA formulations were further evaluated for the parameters like body weight change, food and water intake and biochemical parameters like lipid profile, cardiovascular risk and complete blood count using standard parameters. From the hypoglycemic studies of four most effective HAFA formulation, it was revealed that a single dose of HAFA 2, 4, 8 and 10 did not reduced the blood glucose below the normal level, whereas glibenclamide did and caused hypoglycemia. Streptozotocin-nicotinamide induced anti-hyperglycemic studies revealed that HAFA potentially reduced and maintained blood glucose level to near normal. Out of four formulations, HAFA 4 not only showed significant result in hypoglycemic study, but it also showed significant activities in both acute and sub acute anti-hyperglycemic study. In acute study HAFA 4 reduced fasting blood glucose by 48.96%, in sub-acute study reduction was observed 75.34% followed by HAFA 10, 2 and 8. Apart from that HAFA 4 significantly reversed and improved body weight change by 23% and water and food intake by 45 and 58%. HAFA 4 formulation significantly acted on biochemical parameters and increased plasma insulin by approx 117%, decreased HOMA-IR by 42%, HbA1c by 58% and significantly reversed the alteration of complete blood count, thus prevented from anemia. HAFA 4 significantly reverted the altered lipid profile to near normal. Thus, by research study it was concluded that, HAFA 4 formulations significantly improved glucose tolerance and effectively controlled blood glucose, without causing hypoglycemia. It significantly improved mean body weight, normalized food and water intake, corrected diabetes induced anemia, and reversed the altered lipid profile to near normal after 28 days of continuous treatment. Thus HAFA 4 was considered to be safer and effective antidiabetic with potential to prevent development of other associated complications.

Cite this article:
Vikash Gupta, Mohan Lal Kori. Potential impact of Novel Polyherbal Formulations on Streptozotocin-Nicotinamide Induced Diabetic wistar rats. Research Journal of Pharmacy and Technology 2023; 16(4):1607-6. doi: 10.52711/0974-360X.2023.00263

Vikash Gupta, Mohan Lal Kori. Potential impact of Novel Polyherbal Formulations on Streptozotocin-Nicotinamide Induced Diabetic wistar rats. Research Journal of Pharmacy and Technology 2023; 16(4):1607-6. doi: 10.52711/0974-360X.2023.00263   Available on:

1.    Singh VP, Bali A, Singh N, et al. Advanced Glycation End Products and Diabetic Complications, The Korean Journal of Physiology and Pharmacology: official journal of the Korean Physiological Society and the Korean Society of Pharmacology. 2014; 18(1), 1–14.
2.    Umarkar AR, Raut AK, Sonone SS, Pawar SS, Deshmukh RS, Bharude NV. Dibetes in India: A Review. Research J. Pharmacology and Pharmacodynamics. 2011; 3(6): 345-352.
3.    Dewangan V, Pandey H. Pathophysiology and Management of Diabetes: A Review. Res. J. Pharmacology and Pharmacodynamics. 2016; 8(3): 219-222.
4.    Patel DK, Prasad SK, et al, An Overview on Antidiabetic Medicinal Plants Having Insulin Mimetic Property. Asian Pacific Journal of Tropical Biomedicine. 2012; 2(4), 320–330. (12)60032-X.
5.    Cerf ME. Beta Cell Dysfunction and Insulin Resistance, Frontiers in Endocrinology, 2013; 4, 37.
6.    Martín-Timón I, Sevillano-Collantes C, Segura-Galindo A, Del Cañizo-Gómez FJ. Type 2 diabetes and cardiovascular disease: Have all risk factors the same strength? World J Diabetes. 2014; 5(4):444-470. doi:10.4239/wjd.v5.i4.444.
7.    Lee KW, Ching SM, Ramachandran V. et al. Prevalence and Risk Factors of Gestational Diabetes Mellitus in Asia: A Systematic Review and Meta-Analysis. BMC Pregnancy Childbirth. 2018; 18, 494.
8.    Hicks CW, Selvin E. Epidemiology of Peripheral Neuropathy and Lower Extremity Disease in Diabetes. Current Diabetes Reports. 2019; 19(10), 86.
9.    Nushrat P, Roy A, Prasad P, Diabetes Mellitus–Pathophysiology and Herbal Management. UK Journal of Pharmaceutical Biosciences. 2017; 5. 34.
10.    Hazaratali P, Vegunarani. M. Study on Complications of Diabetes Mellitus among the Diabetic Patients. Asian J. Nur. Edu. and Research. 2016; 6(2): 171-182.
11.    Virani SS, Alonso A, Benjamin EJ, et al., On Behalf of The American Heart Association Council on Epidemiology And Prevention Statistics Committee And Stroke Statistics Subcommittee, Heart Disease And Stroke Statistics 2020 Update: a report from the American Heart Association. Circulation. 2020; 141:e139 – e596.
12.    Babitt JL and Lin HY, Mechanisms of Anemia in CKD, Journal of the American Society of Nephrology. 2012; 23: 1631–1634.
13.    Barbieri J, Fontela PC, Winkelmann ER, et al, Anemia In Patients With Type 2 Diabetes Mellitus. Anemia. 2015, 354737.
14.    Karimi A, Majlesi M, and Rafieian-Kopaei M. Herbal versus Synthetic Drugs; Beliefs and Facts. Journal of Nephropharmacology. 2015; 4(1), 27–30.
15.    Kooti W, Farokhipour M, Asadzadeh Z, et al. The Role of Medicinal Plants in the Treatment of Diabetes: A Systematic Review. Electronic Physician. 2016; 8 (1), 1832–1842.
16.    Parasuraman S, Thing GS, and Dhanaraj SA. Polyherbal Formulation: Concept of Ayurveda. Pharmacognosy Reviews. 2014; 8(16), 73–80.
17.    Kumar S, Dobos GJ, and Rampp T. The Significance of Ayurvedic Medicinal Plants. Journal of Evidence-Based Complementary and Alternative Medicine. 2017; 22(3), 494–501.
18.    Bonner WS. Morphological Evidence of Pancreatic Polarity of Beta Cells within Islets of Langerhans. Diabetes. 1988; 37:616-21.
19.    Rajagopal K, Sasikala K and Ragavan B. Hypoglycemic and Antihyperglycemic Activity of Nymphaea stellata Flowers in Normal and Alloxan Diabetic Rats, Pharmaceutical Biology. 2008; 46:9, 654-659, .
20.    Nalla S, Goli V, Sabat M, Komati S, Begam N, Kokkirala VR. Salubrious Effect of Ethanolic Extract of Cassia auriculata Linn., in Streptazotocin-Nicotinamide induced Diabetes in Rat Model. Asian J. Pharm. Tech. 2(3): July-Sept. 2012; Page 104-106.
21.    Naik SR, Mandlik RV, Desai SK. Antidiabetic Activity of a Polyherbal Formulation (DRF/AY/5001). Indian J Exp Biol. 2008; 46: 599-606.
22.    Chattopadhyay RR. A Comparative Evaluation of Some Blood Sugar Lowering Agents of Plant Origin. J Ethnopharmacol. 1999; 67:367-72.
23.    Pellegrino MP, Broca C, Gross R, et al., Development Of A New Model Of Type II Diabetes In Adult Rats Administered With Streptozotocin And Nicotinamide. Diabetes. 1998, 47: 224– 229.
24.    Rakieten N, Rakieten ML and Nadkarni MV, Studies On The Diabetic Action Of Streptozotocin. Cancer Chemotherapy Reports. 1963; 29, 91-98.
25.    Shirwaikar A, Rajendran K, Barik R. Effect of Aqueous Bark Extract of Garuga Pinnata Roxb. In Streptozotocin-Nicotinamide Induced Type-II Diabetes Mellitus. J Ethnopharmacolgy. 2006; 107: 285-290.
26.    Babu S, et al., Restoration of Altered Carbohydrate and Lipid Metabolism by Hyponidd, A Herbomineral Formulation In Streptozotocin-Induced Diabetic Rats. Asian J. Biochem. 2008; 3: 90-98.
27.    Gopalan SP, Sorimuthu PS, Modulatory Effects of Fisetin, A Bioflavonoid, On Hyperglycemia By Attenuating The Key Enzymes of Carbohydrate Metabolism In Hepatic And Renal Tissues In Streptozotocin-Induced Diabetic Rats, European Journal of Pharmacology. 2011, 668(3), 492-496,
28.    Budhwani AK, Shrivastava B, Singhai AK, Gupta P. Antihyperglycemic activity of ethanolic extract of leaves of Dioscorea japonica in STZ-induced diabetic rats. Research J. Pharm. and Tech., 2012; 5(4): 553-557.
29.    Akbarzadeh A, Norouzian D, Mehrabi MR, et al. Induction of Diabetes by Streptozotocin in Rats. Indian Journal of Clinical Biochemistry. 2007; 22(2), 60–64.
30.    Almugadam BS, Yang P, Tang L, Analysis of Jejunum microbiota of HFD/STZ Diabetic Rats, Biomedicine and  Pharmacotherapy. 2021; 138, 111094.
31.    Bharti SK, Kumar A, Prakash O, et al. Essential Oil of Cymbopogon citratus against Diabetes: Validation By in-vivo, Experiments and Computational Studies. J Bioanal Biomed. 2013; 5: 194-203.
32.    Nayak Y, Hillemane V, Daroji VK, et al. Antidiabetic Activity of Benzopyrone Analogues in Nicotinamide-Streptozotocin Induced Type 2 Diabetes in Rats, The Scientific World Journal. 2014, (2014):12
33.    Nayak SS, Pattabiraman TN. A New Colorimetric Method for the Estimation of Glycosylated Hemoglobin. Clin.Chim.Acta. 1981; 109 (3):267-74. .
34.    Bannon P. Effect of Ph on the Elimination of the Labile Fraction of Glycosylated Hemoglobin. Clinical Chemistry. 1982; 28: 2183.
35.    Dacie J, Lewis S. Practical Hematology. 7 Ed: Edinburgh: ELBS with Churchill Livingstone; 1991.
36.    Drabkin DL, Austin JM. Spectrophotometric Constants for Common Haemoglobin Derivatives in Human, Dog and Rabbit Blood. J Biol.Chem. 1932; 98: 719–33.
37.    Alexander R, Grifiths J. Basic Biochemical Methods. 2 Ed. New York: Wiley-Liss; 1993. 60.
38.    Osim E, et al. Experimental Physiology Manual. 3 Ed: Calabar: University Of Calabar, Dept. Physiol; 2004.
39.    Gupta V, et al. Antihyperglycemic effect of Diospyros melanoxylon (Roxb.) bark against Alloxan induced diabetic rats. 2009; International Journal of Pharm. Tech Research, Vol.1, No.2, 196-20.
40.    Allain CC, Chan CSG, Richmond U, et al. Enzymatic Determination of Total Serum Cholesterol. Clin.Chem. 1974; 20:470-475.
41.    McGowan MW, et al. A peroxidase-coupled method for the colorimetric determination of serum triglycerides. Clin Chem. 1983; Mar; 29(3):538-42.
42.    Izzo CFG, Murador E. Improved Method for the Determination of High Density Lipoprotein Cholesterol I. Isolation of high-density lipoproteins by the use of polyethylene glycol 6000. ClinChem. 1981; 27: 371-374.
43.    Friedewald WT, Levy RI, Fredrickson DS. Estimation of the Concentration of Low-Density Lipoprotein Cholesterol in Plasma, Without Use of the Preparative Ultracentrifuge. Clin Chem. 1972; 18(6):499-502.
44.    King AJ.  The Use of Animal Models in Diabetes Research. British Journal of Pharmacology. 2012; 166(3), 877–894.
45.    Brahmachari, G.  Bio-Flavonoids with Promising Antidiabetic Potentials: A Critical Survey. In: Tiwari, V.K., Mishra, B. B., Editors. Opportunity, Challenge and Scope of Natural Products in Medicinal Chemistry. Trivandrum: Research Signpost. 2011; 2: 187-212.
46.    Devaraj S, Jialal I. The Role of Dietary Supplementation with Plant Sterols and Stanols in the Prevention of Cardiovascular Disease, Nutrition Reviews. 2006; 64, (7) 348–354,
47.    Alkhalidy H, Moore W, Wang A, et al, Kaempferol Ameliorates Hyperglycemia Through Suppressing Hepatic Gluconeogenesis And Enhancing Hepatic Insulin Sensitivity In Diet-Induced Obese Mice. J NutrBiochem. 2018; 58: 90-101.
48.    Khalid S, et al.  Ameliorative Effect of Kaempferol, A Flavonoid, On Oxidative Stress In Streptozotocin-Induced Diabetic Rats, Redox Report. 2015; 20:5, 198-209.
49.    Patel DK, Prasad SK, Kumar R, et al. An Overview on Antidiabetic Medicinal Plants Having Insulin Mimetic Property. Asian Pacific Journal of Tropical Biomedicine. 2012, 2(4), 320–330.
50.    Pari L, Latha M.  Antihyperglycaemic Effect of Scoparia dulcis. Effect On Key Metabolic Enzymes of Carbohydrate Metabolism in Streptozotocin- Induced Diabetes, Pharmaceutical Biology. 2005; 42: 8, 570-576,  .
51.    Friedman MI, Ramirez I. Food Intake in Diabetic Rats: Relationship to Metabolic Effects of Insulin Treatment. PhysiolBehav. 1994; 56 (2):373-8. .
52.    Arun GS and Ramesh KG.  Improvement of Insulin Sensitivity by Perindopril in Spontaneously Hypertensive and Streptozotocin Diabetic Rats. Indian Journal of Pharmacology. 2002; 34, 156-164.
53.    Oyedemi SO, et al. Antidiabetic and Hematological Effect of Aqueous Extract of Stem Bark of Afzelia africana (Smith) On Streptozotocin-Induced Diabetic Wistar Rats. Asian Pacific Journal of Tropical Biomedicine. 2011; 1(5), 353–358. (11)60079-8.
54.    Ochuko L, Erukainure, Osaretin AT. et al. Hematological And Biochemical Changes In Diabetic Rats Fed With Fiber-Enriched Cake, Journal Of Acute Medicine. 2013; 3, (2), 39-44.
55.    Schneider DJ, Factors Contributing To Increased Platelet Reactivity in People with Diabetes. Diabetes Care. 2009; 32(4), 525–527.
56.    Ikewuchi Jude Chigozie, Ikewuchi Catherine Chidinma. Hypoglycemic, Hypocholesterolemic, Anti-Anemic and Ocular-Protective Effects of an Aqueous Extract of the Rhizomes of Sansevieria liberica Gérôme and Labroy (Agavaceae) on alloxan induced diabetic Wistar rats. Asian J. Pharm. Tech. 2011; 1(4): 137-148.
57.    Muthukumaran P, Begum VH. Effect of Poorna Chandrodayam Chendooram (PCM - Metallic Drug) on Lipid Profile, Liver Function and Kidney Function Parameters of Rats. Asian J. Pharm. Ana. 2020; 10(1):27-31.
58.    Jain KA. A Mechanistic Approach to Determination of Anti-diabetic activity of Calystegia sepium R.Br. Flowering plants in normal and Streptozotocin induced rats. Asian J. Res. Pharm. Sci. 2014; 4(2): 55-70.
59.    Murali B, Upadhyaya UM, Goyal RK. Effect of Chronic Treatment with Enicostemma littoralein Non-Insulin Dependent Diabetic (NIDDM) Rats. J Ethnopharmacol. 2002; 81:199-204.
60.    Hirunpanich V, Utaipat A, Morales NP, et al. Antioxidant Effects of Aqueous Extracts from Dried Calyx of Hibiscus sabdariffa Linn. (Roselle) in vitro using rat low-density lipoprotein (LDL). Biological and  Pharmaceutical Bulletin. 2005; 28(3), 481–484.
61.    Kazemi T, Hajihosseini M, Moossavi M, et al. Cardiovascular Risk Factors and Atherogenic Indices in an Iranian Population: Birjand East of Iran. Clinical Medicine Insights. Cardiology. 2018; 12, 1179546818759286.
62.    Yokozawa T, Kim H, Cho, E. Erythritol Attenuates the Diabetic Oxidative Stress through Modulating Glucose Metabolism and Lipid Peroxidation in Streptozotocin-Induced Diabetic Rats. Journal of Agricultural and Food Chemistry. 2002, 50. 5485-9.

Recomonded Articles:

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

56th percentile
Powered by  Scopus

SCImago Journal & Country Rank

Recent Articles


Not Available